NCI and Cancer Research UK to announce new partnership

WHAT: Join the National Cancer Institute (NCI) and Cancer Research UK as we officially announce the launch of Cancer Grand Challenges to the cancer research community. At this virtual event, attendees will learn how this program will facilitate global collaboration and innovation to address some of the toughest challenges that are slowing progress against cancer.

Through Cancer Grand Challenges, NCI and Cancer Research UK will solicit novel ideas from multidisciplinary research teams from around the world that offer the potential for bold advances in cancer research and improve outcomes for people affected by cancer.

WHO: Feature speakers will include:

• Norman E. Sharpless, MD, Director, NCI
• Dinah S. Singer, PhD, Deputy Director, NCI
• Michelle Mitchell OBE, Chief Executive, Cancer Research UK
• Sir Paul Nurse, Chair, CGC Scientific Committee
• Iain Foulkes, PhD, Executive Director of Research & Innovation, Cancer Research UK

WHEN: Thursday, August 27, 2020, 15:30 BST / 10:30 AM ET / 07:30 AM PT

WHERE: Register to attend the virtual event at

https:/

partnership

.

###

About the National Cancer Institute (NCI):

NCI leads the National Cancer Program and NIH’s efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI website at cancer.gov or call NCI’s contact center, the Cancer Information Service, at 1-800-4-CANCER (1-800-422-6237).

About the National Institutes of Health (NIH):

NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit nih.gov.